Labcyte Inc. Announces Collaboration With AstraZeneca PLC (AZN) to Develop Acoustic Sample Handling for Mass Spectrometry to Advance Drug Discovery
9/25/2013 9:27:29 AM
SUNNYVALE, Calif.--(BUSINESS WIRE)--Labcyte Inc. today announced a collaboration with AstraZeneca to use acoustic dispensing combined with mass spectrometry to greatly advance drug discovery applications. Labcyte, who developed and commercialized acoustic liquid handling, recently developed techniques for the direct loading of samples into mass spectrometers. This capability creates the potential for high throughput, low cost, label-free analysis. AstraZeneca is supporting this development effort with the goal of expanding mass spectrometry-based analysis throughout the entire drug discovery and development process.
Help employers find you! Check out all the jobs and post your resume.
comments powered by